Global Radiopharmaceutical Market Size, Share, Growth Analysis Report - Forecast 2034
Radiopharmaceutical Market By Radioisotope Type (Technetium-99, Fluorine-18, Iodine-131, and Leutetium-177), By Application (Oncology, Cardiology, Gastroenterology, Neuroendocrinology, Neurology, and Nephrology), Source (Cyclotrons and Nuclear Reactors), End-User (Hospitals and Diagnostic Labs), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Pharmaceutical Report Format : PDF
Pages: 190 Report Code: ZMR-86
Published Date: Mar-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 6.45 Billion | USD 13.98 Billion | 8.1% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Radiopharmaceutical Market, (2022 - 2028) (USD Billion)
- 2.2 Global Radiopharmaceutical Market : snapshot
- Chapter 3. Global Radiopharmaceutical Market - Industry Analysis
- 3.1 Radiopharmaceutical Market: Market Dynamics
- 3.2 Market Drivers
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By By Radioisotope Type
- 3.7.2 Market attractiveness analysis By By Application
- 3.7.3 Market attractiveness analysis By By Source
- 3.7.4 Market attractiveness analysis By By End-User
- Chapter 4. Global Radiopharmaceutical Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Radiopharmaceutical Market: company market share, 2021
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Radiopharmaceutical Market - By Radioisotope Type Analysis
- 5.1 Global Radiopharmaceutical Market overview: By By Radioisotope Type
- 5.1.1 Global Radiopharmaceutical Market share, By By Radioisotope Type, 2021 and 2028
- 5.2 Technetium-99
- 5.2.1 Global Radiopharmaceutical Market by Technetium-99, 2022 - 2028 (USD Billion)
- 5.3 Fluorine-18
- 5.3.1 Global Radiopharmaceutical Market by Fluorine-18, 2022 - 2028 (USD Billion)
- 5.4 Iodine-131
- 5.4.1 Global Radiopharmaceutical Market by Iodine-131, 2022 - 2028 (USD Billion)
- 5.5 Leutetium-177
- 5.5.1 Global Radiopharmaceutical Market by Leutetium-177, 2022 - 2028 (USD Billion)
- 5.1 Global Radiopharmaceutical Market overview: By By Radioisotope Type
- Chapter 6. Global Radiopharmaceutical Market - By Application Analysis
- 6.1 Global Radiopharmaceutical Market overview: By By Application
- 6.1.1 Global Radiopharmaceutical Market share, By By Application, 2021 and 2028
- 6.2 Oncology
- 6.2.1 Global Radiopharmaceutical Market by Oncology, 2022 - 2028 (USD Billion)
- 6.3 Cardiology
- 6.3.1 Global Radiopharmaceutical Market by Cardiology, 2022 - 2028 (USD Billion)
- 6.4 Gastroenterology
- 6.4.1 Global Radiopharmaceutical Market by Gastroenterology, 2022 - 2028 (USD Billion)
- 6.5 Neuroendocrinology
- 6.5.1 Global Radiopharmaceutical Market by Neuroendocrinology, 2022 - 2028 (USD Billion)
- 6.6 Neurology
- 6.6.1 Global Radiopharmaceutical Market by Neurology, 2022 - 2028 (USD Billion)
- 6.7 Nephrology
- 6.7.1 Global Radiopharmaceutical Market by Nephrology, 2022 - 2028 (USD Billion)
- 6.1 Global Radiopharmaceutical Market overview: By By Application
- Chapter 7. Global Radiopharmaceutical Market - By Source Analysis
- 7.1 Global Radiopharmaceutical Market overview: By By Source
- 7.1.1 Global Radiopharmaceutical Market share, By By Source, 2021 and 2028
- 7.2 Cyclotrons
- 7.2.1 Global Radiopharmaceutical Market by Cyclotrons, 2022 - 2028 (USD Billion)
- 7.3 Nuclear Reactors
- 7.3.1 Global Radiopharmaceutical Market by Nuclear Reactors, 2022 - 2028 (USD Billion)
- 7.1 Global Radiopharmaceutical Market overview: By By Source
- Chapter 8. Global Radiopharmaceutical Market - By End-User Analysis
- 8.1 Global Radiopharmaceutical Market overview: By By End-User
- 8.1.1 Global Radiopharmaceutical Market share, By By End-User, 2021 and 2028
- 8.2 Hospitals
- 8.2.1 Global Radiopharmaceutical Market by Hospitals, 2022 - 2028 (USD Billion)
- 8.3 Diagnostic Labs
- 8.3.1 Global Radiopharmaceutical Market by Diagnostic Labs, 2022 - 2028 (USD Billion)
- 8.1 Global Radiopharmaceutical Market overview: By By End-User
- Chapter 9. Radiopharmaceutical Market - Regional Analysis
- 9.1 Global Radiopharmaceutical Market Regional Overview
- 9.2 Global Radiopharmaceutical Market Share, by Region, 2021 & 2028 (USD Billion)
- 9.3. North America
- 9.3.1 North America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.3.1.1 North America Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
- 9.3.1 North America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.4 North America Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
- 9.4.1 North America Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
- 9.5 North America Radiopharmaceutical Market, by By Application, 2022 - 2028
- 9.5.1 North America Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
- 9.6 North America Radiopharmaceutical Market, by By Source, 2022 - 2028
- 9.6.1 North America Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
- 9.7 North America Radiopharmaceutical Market, by By End-User, 2022 - 2028
- 9.7.1 North America Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
- 9.4. Europe
- 9.4.2 Europe Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.4.2.1 Europe Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
- 9.4.2 Europe Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.4 Europe Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
- 9.4.1 Europe Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
- 9.5 Europe Radiopharmaceutical Market, by By Application, 2022 - 2028
- 9.5.1 Europe Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
- 9.6 Europe Radiopharmaceutical Market, by By Source, 2022 - 2028
- 9.6.1 Europe Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
- 9.7 Europe Radiopharmaceutical Market, by By End-User, 2022 - 2028
- 9.7.1 Europe Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
- 9.5. Asia Pacific
- 9.5.3 Asia Pacific Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.5.3.1 Asia Pacific Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
- 9.5.3 Asia Pacific Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.4 Asia Pacific Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
- 9.4.1 Asia Pacific Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
- 9.5 Asia Pacific Radiopharmaceutical Market, by By Application, 2022 - 2028
- 9.5.1 Asia Pacific Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
- 9.6 Asia Pacific Radiopharmaceutical Market, by By Source, 2022 - 2028
- 9.6.1 Asia Pacific Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
- 9.7 Asia Pacific Radiopharmaceutical Market, by By End-User, 2022 - 2028
- 9.7.1 Asia Pacific Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
- 9.6. Latin America
- 9.6.4 Latin America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.6.4.1 Latin America Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
- 9.6.4 Latin America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.4 Latin America Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
- 9.4.1 Latin America Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
- 9.5 Latin America Radiopharmaceutical Market, by By Application, 2022 - 2028
- 9.5.1 Latin America Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
- 9.6 Latin America Radiopharmaceutical Market, by By Source, 2022 - 2028
- 9.6.1 Latin America Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
- 9.7 Latin America Radiopharmaceutical Market, by By End-User, 2022 - 2028
- 9.7.1 Latin America Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
- 9.7. The Middle-East and Africa
- 9.7.5 The Middle-East and Africa Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.7.5.1 The Middle-East and Africa Radiopharmaceutical Market, by Country, 2022 - 2028 (USD Billion)
- 9.7.5 The Middle-East and Africa Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 9.4 The Middle-East and Africa Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028
- 9.4.1 The Middle-East and Africa Radiopharmaceutical Market, by By Radioisotope Type, 2022 - 2028 (USD Billion)
- 9.5 The Middle-East and Africa Radiopharmaceutical Market, by By Application, 2022 - 2028
- 9.5.1 The Middle-East and Africa Radiopharmaceutical Market, by By Application, 2022 - 2028 (USD Billion)
- 9.6 The Middle-East and Africa Radiopharmaceutical Market, by By Source, 2022 - 2028
- 9.6.1 The Middle-East and Africa Radiopharmaceutical Market, by By Source, 2022 - 2028 (USD Billion)
- 9.7 The Middle-East and Africa Radiopharmaceutical Market, by By End-User, 2022 - 2028
- 9.7.1 The Middle-East and Africa Radiopharmaceutical Market, by By End-User, 2022 - 2028 (USD Billion)
- Chapter 10. Company Profiles
- 10.1 Jubilant Pharmova
- 10.1.1 Overview
- 10.1.2 Financials
- 10.1.3 Product Portfolio
- 10.1.4 Business Strategy
- 10.1.5 Recent Developments
- 10.2 Lantheus Holdings Inc.
- 10.2.1 Overview
- 10.2.2 Financials
- 10.2.3 Product Portfolio
- 10.2.4 Business Strategy
- 10.2.5 Recent Developments
- 10.3 Mallinckrodt Pharmaceuticals
- 10.3.1 Overview
- 10.3.2 Financials
- 10.3.3 Product Portfolio
- 10.3.4 Business Strategy
- 10.3.5 Recent Developments
- 10.4 Cardinal Health Inc.
- 10.4.1 Overview
- 10.4.2 Financials
- 10.4.3 Product Portfolio
- 10.4.4 Business Strategy
- 10.4.5 Recent Developments
- 10.5 GE Healthcare
- 10.5.1 Overview
- 10.5.2 Financials
- 10.5.3 Product Portfolio
- 10.5.4 Business Strategy
- 10.5.5 Recent Developments
- 10.6 Advanced Accelerator Applications
- 10.6.1 Overview
- 10.6.2 Financials
- 10.6.3 Product Portfolio
- 10.6.4 Business Strategy
- 10.6.5 Recent Developments
- 10.7 The Bracco Group
- 10.7.1 Overview
- 10.7.2 Financials
- 10.7.3 Product Portfolio
- 10.7.4 Business Strategy
- 10.7.5 Recent Developments
- 10.8 Eczacibasi-Monrol Nuclear Products
- 10.8.1 Overview
- 10.8.2 Financials
- 10.8.3 Product Portfolio
- 10.8.4 Business Strategy
- 10.8.5 Recent Developments
- 10.9 Nordion Inc.
- 10.9.1 Overview
- 10.9.2 Financials
- 10.9.3 Product Portfolio
- 10.9.4 Business Strategy
- 10.9.5 Recent Developments
- 10.10 Bayer AG
- 10.10.1 Overview
- 10.10.2 Financials
- 10.10.3 Product Portfolio
- 10.10.4 Business Strategy
- 10.10.5 Recent Developments
- 10.11 IBA Molecular Imaging Private Limited
- 10.11.1 Overview
- 10.11.2 Financials
- 10.11.3 Product Portfolio
- 10.11.4 Business Strategy
- 10.11.5 Recent Developments
- 10.12 Siemens Healthineers AG.
- 10.12.1 Overview
- 10.12.2 Financials
- 10.12.3 Product Portfolio
- 10.12.4 Business Strategy
- 10.12.5 Recent Developments
- 10.1 Jubilant Pharmova
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 4. Porter’s Five Forces Analysis
- 5. Global Radiopharmaceutical Market attractiveness, By By Radioisotope Type
- 6. Global Radiopharmaceutical Market attractiveness, By By Application
- 7. Global Radiopharmaceutical Market attractiveness, By By Source
- 8. Global Radiopharmaceutical Market attractiveness, By By End-User
- 9. Global Radiopharmaceutical Market share by By Radioisotope Type, 2022 and 2028 (USD Billion)
- 10. Global Radiopharmaceutical Market by Technetium-99, 2022 - 2028 (USD Billion)
- 11. Global Radiopharmaceutical Market by Fluorine-18, 2022 - 2028 (USD Billion)
- 12. Global Radiopharmaceutical Market by Iodine-131, 2022 - 2028 (USD Billion)
- 13. Global Radiopharmaceutical Market by Leutetium-177, 2022 - 2028 (USD Billion)
- 14. Global Radiopharmaceutical Market share by By Application, 2022 and 2028 (USD Billion)
- 15. Global Radiopharmaceutical Market by Oncology, 2022 - 2028 (USD Billion)
- 16. Global Radiopharmaceutical Market by Cardiology, 2022 - 2028 (USD Billion)
- 17. Global Radiopharmaceutical Market by Gastroenterology, 2022 - 2028 (USD Billion)
- 18. Global Radiopharmaceutical Market by Neuroendocrinology, 2022 - 2028 (USD Billion)
- 19. Global Radiopharmaceutical Market by Neurology, 2022 - 2028 (USD Billion)
- 20. Global Radiopharmaceutical Market by Nephrology, 2022 - 2028 (USD Billion)
- 21. Global Radiopharmaceutical Market share by By Source, 2022 and 2028 (USD Billion)
- 22. Global Radiopharmaceutical Market by Cyclotrons, 2022 - 2028 (USD Billion)
- 23. Global Radiopharmaceutical Market by Nuclear Reactors, 2022 - 2028 (USD Billion)
- 24. Global Radiopharmaceutical Market share by By End-User, 2022 and 2028 (USD Billion)
- 25. Global Radiopharmaceutical Market by Hospitals, 2022 - 2028 (USD Billion)
- 26. Global Radiopharmaceutical Market by Diagnostic Labs, 2022 - 2028 (USD Billion)
- 27. Global Radiopharmaceutical Market share, by Region, 2022 and 2028
- 28. North America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 29. Europe Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 30. Asia Pacific Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 31. Latin America Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
- 32. The Middle-East and Africa Radiopharmaceutical Market, 2022 - 2028 (USD Billion)
Table Of Tables
- 1. Global Radiopharmaceutical Market: Snapshot
- 2. Drivers of the Radiopharmaceutical Market: impact analysis
- 3. North America Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 4. North America Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 5. North America Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 6. North America Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 7. U.S. Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 8. U.S. Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 9. U.S. Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 10. U.S. Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 11. Canada Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 12. Canada Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 13. Canada Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 14. Canada Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 15. Europe Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 16. Europe Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 17. Europe Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 18. Europe Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 19. Germany Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 20. Germany Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 21. Germany Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 22. Germany Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 23. France Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 24. France Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 25. France Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 26. France Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 27. U.K. Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 28. U.K. Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 29. U.K. Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 30. U.K. Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 31. Italy Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 32. Italy Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 33. Italy Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 34. Italy Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 35. Spain Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 36. Spain Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 37. Spain Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 38. Spain Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 39. Rest of Europe Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 40. Rest of Europe Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 41. Rest of Europe Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 42. Rest of Europe Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 43. Asia Pacific Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 44. Asia Pacific Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 45. Asia Pacific Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 46. Asia Pacific Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 47. China Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 48. China Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 49. China Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 50. China Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 51. Japan Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 52. Japan Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 53. Japan Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 54. Japan Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 55. India Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 56. India Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 57. India Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 58. India Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 59. South Korea Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 60. South Korea Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 61. South Korea Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 62. South Korea Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 63. South-East Asia Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 64. South-East Asia Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 65. South-East Asia Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 66. South-East Asia Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 67. Rest of Asia Pacific Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 68. Rest of Asia Pacific Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 69. Rest of Asia Pacific Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 70. Rest of Asia Pacific Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 71. Latin America Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 72. Latin America Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 73. Latin America Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 74. Latin America Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 75. Brazil Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 76. Brazil Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 77. Brazil Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 78. Brazil Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 79. Mexico Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 80. Mexico Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 81. Mexico Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 82. Mexico Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 83. Rest of Latin America Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 84. Rest of Latin America Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 85. Rest of Latin America Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 86. Rest of Latin America Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 87. The Middle-East and Africa Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 88. The Middle-East and Africa Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 89. The Middle-East and Africa Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 90. The Middle-East and Africa Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 91. GCC Countries Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 92. GCC Countries Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 93. GCC Countries Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 94. GCC Countries Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 95. South Africa Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 96. South Africa Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 97. South Africa Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 98. South Africa Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
- 99. Rest of Middle-East Africa Radiopharmaceutical Market revenue, By By Radioisotope Type, 2022 - 2028 (USD Billion)
- 100. Rest of Middle-East Africa Radiopharmaceutical Market revenue, By By Application, 2022 - 2028 (USD Billion)
- 101. Rest of Middle-East Africa Radiopharmaceutical Market revenue, By By Source, 2022 - 2028 (USD Billion)
- 102. Rest of Middle-East Africa Radiopharmaceutical Market revenue, By By End-User, 2022 - 2028 (USD Billion)
Methodology
FrequentlyAsked Questions
Radiopharmaceuticals are a class of radioactive substances that can be utilized for therapeutic purpose or diagnostic purpose.
The global radiopharmaceutical market is expected to grow due to increasing demand for targeted cancer therapies, growing use of nuclear medicine in diagnostics, and advancements in radiotracers.
According to a study, the global radiopharmaceutical market size was worth around USD 6.45 Billion in 2024 and is expected to reach USD 13.98 Billion by 2034.
The global radiopharmaceutical market is expected to grow at a CAGR of 8.1% during the forecast period.
North America is expected to dominate the radiopharmaceutical market over the forecast period.
Leading players in the global radiopharmaceutical market include Jubilant Pharmova, Lantheus Holdings Inc., Mallinckrodt Pharmaceuticals, Cardinal Health Inc., GE Healthcare, Advanced Accelerator Applications, The Bracco Group, Eczacibasi-Monrol Nuclear Products, Nordion Inc., Bayer AG, IBA Molecular Imaging Private Limited, and Siemens Healthineers AG., among others.
The report explores crucial aspects of the radiopharmaceutical market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
HappyClients
